Massive MS registry tracks 1,000 patients to compare drug safety
NCT ID NCT03291756
Summary
This study is creating a national registry to track 1,000 people with multiple sclerosis (MS) who are starting new approved treatments. Researchers will follow patients over time to compare how well different MS medications work in real-world settings and monitor their safety. The goal is to better understand MS patterns and treatment outcomes through regular check-ins every six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.